OnCyte Diagnostic System addresses crucial medico-economic needs with new diagnostic tests for heart attacks, platelet activity, and neonatal sepsis that can be performed at the point of care or central laboratory. Under cost-containment, central laboratories have emerged as cost centers, driving laboratory tests to sites nearer the patient. . New types of diagnostic information will be required to select and manage patients in order to utilize the new therapeutic regimens. .
Current analyzers are expensive, difficult to use, and often available only in academic centers.
Test results are delayed due to remote lab locations and limited operating hours. Instrument operable around the clock at any clinical or laboratory site. All rights reserved.